author_facet Cozma, Irina
Zhang, Lei
Uddin, James
Lane, Carol
Rees, Aled
Ludgate, Marian
Cozma, Irina
Zhang, Lei
Uddin, James
Lane, Carol
Rees, Aled
Ludgate, Marian
author Cozma, Irina
Zhang, Lei
Uddin, James
Lane, Carol
Rees, Aled
Ludgate, Marian
spellingShingle Cozma, Irina
Zhang, Lei
Uddin, James
Lane, Carol
Rees, Aled
Ludgate, Marian
American Journal of Physiology-Endocrinology and Metabolism
Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
Physiology (medical)
Physiology
Endocrinology, Diabetes and Metabolism
author_sort cozma, irina
spelling Cozma, Irina Zhang, Lei Uddin, James Lane, Carol Rees, Aled Ludgate, Marian 0193-1849 1522-1555 American Physiological Society Physiology (medical) Physiology Endocrinology, Diabetes and Metabolism http://dx.doi.org/10.1152/ajpendo.00177.2007 <jats:p> Apart from evaluating orbital inflammation in Graves’ ophthalmopathy (GO), somatostatin (SST) analogs have been proposed as a therapy, but recent trials were disappointing. We aimed to measure somatostatin receptor (SSTR) expression in orbital tissues ex vivo and determine whether the new broad-affinity analog SOM230 might be of therapeutic use. Orbital adipose/connective tissues from 29 GO patients and 10 normal individuals were analyzed. Transcripts were quantified using SYBR Green and a light cycler. In vitro models were used to investigate whether thyrotropin receptor activation (as occurs via thyroid stimulating antibodies) or adipogenesis affected SSTR expression in primary preadipocytes and to compare the biological activity of octreotide and SOM230 in their modulation. The expression of SSTR1 was significantly higher in GO patients than normal controls ( P = 0.024). Although differences in the expression of SSTR2 were not significant, 39% of GO samples had levels above the 97th percentile of the controls. SSTR3, -4, and -5 were at or below the limit of detection (LOD). The lymphocyte contribution was minimal, since CD3α transcripts were at the LOD. TSH receptor activation did not modulate SSTR expression. An in vitro model of adipogenesis indicated upregulation of SSTR1 and SSTR2 during differentiation. SOM230 produced significantly greater inhibition of orbital preadipocyte proliferation than octreotide. Ex vivo analysis of orbital tissues reveals upregulation of SSTR1 and -2 in a group of GO patients. Adipogenesis, a process occurring in GO orbits, provides one possible explanation for some of the observed increase. </jats:p> Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs American Journal of Physiology-Endocrinology and Metabolism
doi_str_mv 10.1152/ajpendo.00177.2007
facet_avail Online
Free
finc_class_facet Biologie
Medizin
format ElectronicArticle
fullrecord blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1Mi9hanBlbmRvLjAwMTc3LjIwMDc
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1Mi9hanBlbmRvLjAwMTc3LjIwMDc
institution DE-Gla1
DE-Zi4
DE-15
DE-Pl11
DE-Rs1
DE-105
DE-14
DE-Ch1
DE-L229
DE-D275
DE-Bn3
DE-Brt1
DE-Zwi2
DE-D161
imprint American Physiological Society, 2007
imprint_str_mv American Physiological Society, 2007
issn 0193-1849
1522-1555
issn_str_mv 0193-1849
1522-1555
language English
mega_collection American Physiological Society (CrossRef)
match_str cozma2007modulationofexpressionofsomatostatinreceptorsubtypesingravesophthalmopathyorbitsrelevancetonovelanalogs
publishDateSort 2007
publisher American Physiological Society
recordtype ai
record_format ai
series American Journal of Physiology-Endocrinology and Metabolism
source_id 49
title Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_unstemmed Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_full Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_fullStr Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_full_unstemmed Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_short Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_sort modulation of expression of somatostatin receptor subtypes in graves’ ophthalmopathy orbits: relevance to novel analogs
topic Physiology (medical)
Physiology
Endocrinology, Diabetes and Metabolism
url http://dx.doi.org/10.1152/ajpendo.00177.2007
publishDate 2007
physical E1630-E1635
description <jats:p> Apart from evaluating orbital inflammation in Graves’ ophthalmopathy (GO), somatostatin (SST) analogs have been proposed as a therapy, but recent trials were disappointing. We aimed to measure somatostatin receptor (SSTR) expression in orbital tissues ex vivo and determine whether the new broad-affinity analog SOM230 might be of therapeutic use. Orbital adipose/connective tissues from 29 GO patients and 10 normal individuals were analyzed. Transcripts were quantified using SYBR Green and a light cycler. In vitro models were used to investigate whether thyrotropin receptor activation (as occurs via thyroid stimulating antibodies) or adipogenesis affected SSTR expression in primary preadipocytes and to compare the biological activity of octreotide and SOM230 in their modulation. The expression of SSTR1 was significantly higher in GO patients than normal controls ( P = 0.024). Although differences in the expression of SSTR2 were not significant, 39% of GO samples had levels above the 97th percentile of the controls. SSTR3, -4, and -5 were at or below the limit of detection (LOD). The lymphocyte contribution was minimal, since CD3α transcripts were at the LOD. TSH receptor activation did not modulate SSTR expression. An in vitro model of adipogenesis indicated upregulation of SSTR1 and SSTR2 during differentiation. SOM230 produced significantly greater inhibition of orbital preadipocyte proliferation than octreotide. Ex vivo analysis of orbital tissues reveals upregulation of SSTR1 and -2 in a group of GO patients. Adipogenesis, a process occurring in GO orbits, provides one possible explanation for some of the observed increase. </jats:p>
container_issue 6
container_start_page 0
container_title American Journal of Physiology-Endocrinology and Metabolism
container_volume 293
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
_version_ 1792339350259761152
geogr_code not assigned
last_indexed 2024-03-01T15:46:43.712Z
geogr_code_person not assigned
openURL url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Modulation+of+expression+of+somatostatin+receptor+subtypes+in+Graves%E2%80%99+ophthalmopathy+orbits%3A+relevance+to+novel+analogs&rft.date=2007-12-01&genre=article&issn=1522-1555&volume=293&issue=6&pages=E1630-E1635&jtitle=American+Journal+of+Physiology-Endocrinology+and+Metabolism&atitle=Modulation+of+expression+of+somatostatin+receptor+subtypes+in+Graves%E2%80%99+ophthalmopathy+orbits%3A+relevance+to+novel+analogs&aulast=Ludgate&aufirst=Marian&rft_id=info%3Adoi%2F10.1152%2Fajpendo.00177.2007&rft.language%5B0%5D=eng
SOLR
_version_ 1792339350259761152
author Cozma, Irina, Zhang, Lei, Uddin, James, Lane, Carol, Rees, Aled, Ludgate, Marian
author_facet Cozma, Irina, Zhang, Lei, Uddin, James, Lane, Carol, Rees, Aled, Ludgate, Marian, Cozma, Irina, Zhang, Lei, Uddin, James, Lane, Carol, Rees, Aled, Ludgate, Marian
author_sort cozma, irina
container_issue 6
container_start_page 0
container_title American Journal of Physiology-Endocrinology and Metabolism
container_volume 293
description <jats:p> Apart from evaluating orbital inflammation in Graves’ ophthalmopathy (GO), somatostatin (SST) analogs have been proposed as a therapy, but recent trials were disappointing. We aimed to measure somatostatin receptor (SSTR) expression in orbital tissues ex vivo and determine whether the new broad-affinity analog SOM230 might be of therapeutic use. Orbital adipose/connective tissues from 29 GO patients and 10 normal individuals were analyzed. Transcripts were quantified using SYBR Green and a light cycler. In vitro models were used to investigate whether thyrotropin receptor activation (as occurs via thyroid stimulating antibodies) or adipogenesis affected SSTR expression in primary preadipocytes and to compare the biological activity of octreotide and SOM230 in their modulation. The expression of SSTR1 was significantly higher in GO patients than normal controls ( P = 0.024). Although differences in the expression of SSTR2 were not significant, 39% of GO samples had levels above the 97th percentile of the controls. SSTR3, -4, and -5 were at or below the limit of detection (LOD). The lymphocyte contribution was minimal, since CD3α transcripts were at the LOD. TSH receptor activation did not modulate SSTR expression. An in vitro model of adipogenesis indicated upregulation of SSTR1 and SSTR2 during differentiation. SOM230 produced significantly greater inhibition of orbital preadipocyte proliferation than octreotide. Ex vivo analysis of orbital tissues reveals upregulation of SSTR1 and -2 in a group of GO patients. Adipogenesis, a process occurring in GO orbits, provides one possible explanation for some of the observed increase. </jats:p>
doi_str_mv 10.1152/ajpendo.00177.2007
facet_avail Online, Free
finc_class_facet Biologie, Medizin
format ElectronicArticle
format_de105 Article, E-Article
format_de14 Article, E-Article
format_de15 Article, E-Article
format_de520 Article, E-Article
format_de540 Article, E-Article
format_dech1 Article, E-Article
format_ded117 Article, E-Article
format_degla1 E-Article
format_del152 Buch
format_del189 Article, E-Article
format_dezi4 Article
format_dezwi2 Article, E-Article
format_finc Article, E-Article
format_nrw Article, E-Article
geogr_code not assigned
geogr_code_person not assigned
id ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1Mi9hanBlbmRvLjAwMTc3LjIwMDc
imprint American Physiological Society, 2007
imprint_str_mv American Physiological Society, 2007
institution DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161
issn 0193-1849, 1522-1555
issn_str_mv 0193-1849, 1522-1555
language English
last_indexed 2024-03-01T15:46:43.712Z
match_str cozma2007modulationofexpressionofsomatostatinreceptorsubtypesingravesophthalmopathyorbitsrelevancetonovelanalogs
mega_collection American Physiological Society (CrossRef)
physical E1630-E1635
publishDate 2007
publishDateSort 2007
publisher American Physiological Society
record_format ai
recordtype ai
series American Journal of Physiology-Endocrinology and Metabolism
source_id 49
spelling Cozma, Irina Zhang, Lei Uddin, James Lane, Carol Rees, Aled Ludgate, Marian 0193-1849 1522-1555 American Physiological Society Physiology (medical) Physiology Endocrinology, Diabetes and Metabolism http://dx.doi.org/10.1152/ajpendo.00177.2007 <jats:p> Apart from evaluating orbital inflammation in Graves’ ophthalmopathy (GO), somatostatin (SST) analogs have been proposed as a therapy, but recent trials were disappointing. We aimed to measure somatostatin receptor (SSTR) expression in orbital tissues ex vivo and determine whether the new broad-affinity analog SOM230 might be of therapeutic use. Orbital adipose/connective tissues from 29 GO patients and 10 normal individuals were analyzed. Transcripts were quantified using SYBR Green and a light cycler. In vitro models were used to investigate whether thyrotropin receptor activation (as occurs via thyroid stimulating antibodies) or adipogenesis affected SSTR expression in primary preadipocytes and to compare the biological activity of octreotide and SOM230 in their modulation. The expression of SSTR1 was significantly higher in GO patients than normal controls ( P = 0.024). Although differences in the expression of SSTR2 were not significant, 39% of GO samples had levels above the 97th percentile of the controls. SSTR3, -4, and -5 were at or below the limit of detection (LOD). The lymphocyte contribution was minimal, since CD3α transcripts were at the LOD. TSH receptor activation did not modulate SSTR expression. An in vitro model of adipogenesis indicated upregulation of SSTR1 and SSTR2 during differentiation. SOM230 produced significantly greater inhibition of orbital preadipocyte proliferation than octreotide. Ex vivo analysis of orbital tissues reveals upregulation of SSTR1 and -2 in a group of GO patients. Adipogenesis, a process occurring in GO orbits, provides one possible explanation for some of the observed increase. </jats:p> Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs American Journal of Physiology-Endocrinology and Metabolism
spellingShingle Cozma, Irina, Zhang, Lei, Uddin, James, Lane, Carol, Rees, Aled, Ludgate, Marian, American Journal of Physiology-Endocrinology and Metabolism, Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs, Physiology (medical), Physiology, Endocrinology, Diabetes and Metabolism
title Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_full Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_fullStr Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_full_unstemmed Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_short Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
title_sort modulation of expression of somatostatin receptor subtypes in graves’ ophthalmopathy orbits: relevance to novel analogs
title_unstemmed Modulation of expression of somatostatin receptor subtypes in Graves’ ophthalmopathy orbits: relevance to novel analogs
topic Physiology (medical), Physiology, Endocrinology, Diabetes and Metabolism
url http://dx.doi.org/10.1152/ajpendo.00177.2007